Jimini Health lands $17M to scale safe AI in behavioural health
Jimini Health, a digital health startup focused on behavioural and mental health, has raised $17 million in fresh funding to accelerate the development and deployment of its clinically safe AI tools for care providers.
The round was led by venture firms M13 and Zetta Venture Partners, both known for backing data-driven and AI-first companies. The capital injection will support product expansion, clinical validation, and go‑to‑market efforts with health systems, payers, and specialised clinics.
Building clinically safe AI for mental health
Jimini Health develops AI-powered software designed to support clinicians in managing complex behavioural health cases. Its platform uses advanced AI algorithms to analyse patient histories, engagement patterns and outcomes, aiming to surface timely insights without replacing human judgment.
The company emphasises guardrails and transparency, positioning its tools as clinical decision support rather than autonomous diagnosis. Features typically include risk-flagging dashboards, personalised care pathways and automated but supervised patient follow‑ups, all built to comply with strict data privacy and healthcare regulation standards.
Backers bet on AI to ease provider burnout
Investors such as M13 and Zetta are betting that responsibly deployed AI can help ease the mounting pressure on overburdened mental health systems. Clinicians face soaring demand, documentation overload and limited reimbursement, while patients struggle with long wait times and fragmented care.
By automating routine workflows and highlighting high‑risk cases earlier, Jimini Health aims to free clinicians to focus on complex therapeutic work, not paperwork. The new funding will be used to scale integrations with electronic health record providers, deepen partnerships with insurers, and expand the company’s presence across the United States.
As regulators and professional bodies sharpen their focus on the safety and ethics of AI in healthcare, the company’s explicit commitment to “safe AI” could become a strategic differentiator in a rapidly crowding market.